 | • レポートコード：MRC2109A045 • 出版社/出版日：Transparency Market Research / 2021年7月9日 • レポート形態：英文、PDF、216ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、メトホルミン塩酸塩APIの世界市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、主要インサイト、製品別（メトホルミン塩酸塩、メトホルミン塩酸塩DC、その他）分析、エンドユーザー別分析、剤形別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しております。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・メトホルミン塩酸塩APIの世界市場規模：製品別（メトホルミン塩酸塩、メトホルミン塩酸塩DC、その他） ・メトホルミン塩酸塩APIの世界市場規模：エンドユーザー別 ・メトホルミン塩酸塩APIの世界市場規模：剤形別 ・メトホルミン塩酸塩APIの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Metformin Hydrochloride API Market – Scope of Report
TMR’s report on the global metformin hydrochloride API market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global metformin hydrochloride API market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global metformin hydrochloride API market during the forecast period.
The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global metformin hydrochloride API market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global metformin hydrochloride API market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global metformin hydrochloride API market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global metformin hydrochloride API market.
The report delves into the competitive landscape of the global metformin hydrochloride API market. Key players operating in the global metformin hydrochloride API market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global metformin hydrochloride API market that have been profiled in this report.
Key Questions Answered in Metformin Hydrochloride API Market Report
What are the major drivers, restraints, and opportunities in the market?
What will be the Y-o-Y growth of the global metformin hydrochloride API market between 2021 and 2031?
What are the revenue share projections of key segments of the global metformin hydrochloride API market during the forecast period?
Will North America continue to be the most profitable market for metformin hydrochloride API?
Which factors are anticipated to hamper the global metformin hydrochloride API market during the forecast period?
Which are the leading companies in the global metformin hydrochloride API market?
Research Methodology
A unique methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global metformin hydrochloride API market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary research sources referred to by analysts during the production of the global metformin hydrochloride API market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the metformin hydrochloride API market as primary methods.
These primary research respondents have provided exclusive information during interviews, which serves as a validation from the metformin hydrochloride API market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global metformin hydrochloride API market with accuracy. The study also uses the top-down approach to assess the revenue of each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global metformin hydrochloride API more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Metformin Hydrochloride API Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Metformin Hydrochloride API Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Top 3 Players Operating in the Market Space
5.2. Key Industry Events (mergers, acquisitions, collaborations, approvals, etc.)
5.3. Top Companies by Production Capacity, Production Volume, and Production Amount
5.4. Top Countries by Production Capacity, Production Volume, and Production Amount
5.5. Top Countries by Consumption Volume and Consumption Amount
5.6. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Metformin Hydrochloride API Market Analysis and Forecast, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Metformin Hydrochloride
6.3.2. Metformin Hydrochloride DC
6.3.3. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Metformin Hydrochloride API Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Pharmaceutical Companies
7.3.2. Contract Research Organizations
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Metformin Hydrochloride API Market Analysis and Forecast, by Dosage Form
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Dosage Form, 2017–2031
8.3.1. Tablet
8.3.2. Extended Release Tablet
8.3.3. Oral Solution
8.4. Market Attractiveness Analysis, by Dosage Form
9. Global Metformin Hydrochloride API Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Metformin Hydrochloride API Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Metformin Hydrochloride
10.2.2. Metformin Hydrochloride DC
10.2.3. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Pharmaceutical Companies
10.3.2. Contract Research Organizations
10.3.3. Others
10.4. Market Value Forecast, by Dosage Form, 2017–2031
10.4.1. Tablet
10.4.2. Extended Release Tablet
10.4.3. Oral Solution
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By End-user
10.6.3. By Dosage Form
10.6.4. By Country
11. Europe Metformin Hydrochloride API Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Metformin Hydrochloride
11.2.2. Metformin Hydrochloride DC
11.2.3. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Pharmaceutical Companies
11.3.2. Contract Research Organizations
11.3.3. Others
11.4. Market Value Forecast, by Dosage Form, 2017–2031
11.4.1. Tablet
11.4.2. Extended Release Tablet
11.4.3. Oral Solution
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By End-user
11.6.3. By Dosage Form
11.6.4. By Country/Sub-region
12. Asia Pacific Metformin Hydrochloride API Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Metformin Hydrochloride
12.2.2. Metformin Hydrochloride DC
12.2.3. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Pharmaceutical Companies
12.3.2. Contract Research Organizations
12.3.3. Others
12.4. Market Value Forecast, by Dosage Form, 2017–2031
12.4.1. Tablet
12.4.2. Extended Release Tablet
12.4.3. Oral Solution
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By End-user
12.6.3. By Dosage Form
12.6.4. By Country/Sub-region
13. Latin America Metformin Hydrochloride API Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Metformin Hydrochloride
13.2.2. Metformin Hydrochloride DC
13.2.3. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Pharmaceutical Companies
13.3.2. Contract Research Organizations
13.3.3. Others
13.4. Market Value Forecast, by Dosage Form, 2017–2031
13.4.1. Tablet
13.4.2. Extended Release Tablet
13.4.3. Oral Solution
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By End-user
13.6.3. By Dosage Form
13.6.4. By Country/Sub-region
14. Middle East & Africa Metformin Hydrochloride API Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Metformin Hydrochloride
14.2.2. Metformin Hydrochloride DC
14.2.3. Others
14.3. Market Value Forecast, by End-user, 2017–2031
14.3.1. Pharmaceutical Companies
14.3.2. Contract Research Organizations
14.3.3. Others
14.4. Market Value Forecast, by Dosage Form, 2017–2031
14.4.1. Tablet
14.4.2. Extended Release Tablet
14.4.3. Oral Solution
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By End-user
14.6.3. By Dosage Form
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Auro Laboratories Limited
15.3.1.1. Company Overview
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Abhilasha Pharma Pvt. Ltd.
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. Stanex Drugs & Chemicals Pvt. Ltd.
15.3.3.1. Company Overview
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Fengchen Group Co., Ltd.
15.3.4.1. Company Overview
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. NS Chemicals
15.3.5.1. Company Overview
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Midas Pharma GmbH
15.3.6.1. Company Overview
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Harman Finochem Ltd.
15.3.7.1. Company Overview
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Aarti Drugs Ltd.
15.3.8.1. Company Overview
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Bayer AG
15.3.9.1. Company Overview
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Ipca Laboratories Ltd.
15.3.10.1. Company Overview
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Panacea Biotech Ltd.
15.3.11.1. Company Overview
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis
15.3.12. Aristopharma Ltd.
15.3.12.1. Company Overview
15.3.12.2. Company Financials
15.3.12.3. Growth Strategies
15.3.12.4. SWOT Analysis
15.3.13. Sihuan Pharmaceutical Holdings Group Ltd.
15.3.13.1. Company Overview
15.3.13.2. Company Financials
15.3.13.3. Growth Strategies
15.3.13.4. SWOT Analysis
15.3.14. Intas Pharmaceuticals Ltd.
15.3.14.1. Company Overview
15.3.14.2. Company Financials
15.3.14.3. Growth Strategies
15.3.14.4. SWOT Analysis
15.3.15. Bal Pharma Limited
15.3.15.1. Company Overview
15.3.15.2. Company Financials
15.3.15.3. Growth Strategies
15.3.15.4. SWOT Analysis
15.3.16. Sohan Healthcare Pvt. Ltd.
15.3.16.1. Company Overview
15.3.16.2. Company Financials
15.3.16.3. Growth Strategies
15.3.16.4. SWOT Analysis
15.3.17. JD Chem (I)
15.3.17.1. Company Overview
15.3.17.2. Company Financials
15.3.17.3. Growth Strategies
15.3.17.4. SWOT Analysis
15.3.18. Kothari Phytochemicals & Industries Ltd.
15.3.18.1. Company Overview
15.3.18.2. Company Financials
15.3.18.3. Growth Strategies
15.3.18.4. SWOT Analysis
15.3.19. Turtle Pharma Private Limited
15.3.19.1. Company Overview
15.3.19.2. Company Financials
15.3.19.3. Growth Strategies
15.3.19.4. SWOT Analysis
15.3.20. Shijiazhuang Polee pharmaceutical Co., Ltd.
15.3.20.1. Company Overview
15.3.20.2. Company Financials
15.3.20.3. Growth Strategies
15.3.20.4. SWOT Analysis
15.3.21. Shouguang Fukang Pharmaceutical Co., Ltd.
15.3.21.1. Company Overview
15.3.21.2. Company Financials
15.3.21.3. Growth Strategies
15.3.21.4. SWOT Analysis
15.3.22. USV Private Limited
15.3.22.1. Company Overview
15.3.22.2. Company Financials
15.3.22.3. Growth Strategies
15.3.22.4. SWOT Analysis
15.3.23. Exemed Pharmaceuticals
15.3.23.1. Company Overview
15.3.23.2. Company Financials
15.3.23.3. Growth Strategies
15.3.23.4. SWOT Analysis
15.3.24. Farmhispania Group
15.3.24.1. Company Overview
15.3.24.2. Company Financials
15.3.24.3. Growth Strategies
15.3.24.4. SWOT Analysis
15.3.25. Shandong Keyuan Pharmaceutical Co., Ltd.
15.3.25.1. Company Overview
15.3.25.2. Company Financials
15.3.25.3. Growth Strategies
15.3.25.4. SWOT Analysis
15.3.26. Merck KGaA
15.3.26.1. Company Overview
15.3.26.2. Company Financials
15.3.26.3. Growth Strategies
15.3.26.4. SWOT Analysis
15.3.27. Taj API
15.3.27.1. Company Overview
15.3.27.2. Company Financials
15.3.27.3. Growth Strategies
15.3.27.4. SWOT Analysis
15.3.28. Vistin Pharma AS
15.3.28.1. Company Overview
15.3.28.2. Company Financials
15.3.28.3. Growth Strategies
15.3.28.4. SWOT Analysis
15.3.29. Wanbury Limited
15.3.29.1. Company Overview
15.3.29.2. Company Financials
15.3.29.3. Growth Strategies
15.3.29.4. SWOT Analysis
Table 01: Global Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 04: Global Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 06: North America Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: North America Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 09: Europe Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 11: Europe Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Europe Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 13: Asia Pacific Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Asia Pacific Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 17: Latin America Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Latin America Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Latin America Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 21: Middle East & Africa Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Middle East & Africa Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Middle East & Africa Metformin Hydrochloride API Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031